Studies regarding the role of the ERα variant ERα-36 in promoting GC indicated that its expression, both in terms of protein and mRNA, is higher in gastric tumor tissues than in normal ones, and its presence has been associated with metastasis phenomena, so much so that it can be considered an indicator of the presence of metastases [123]. Here, ESR1 is linked to gastric cancer.